Skip to main content

Regulation of DNA double-strand break repair in Escherichia coli

Principal investigator

Project type
Znanstveno-istraživački projekti
Programme
Research Projects
Financier
Croatian Science Foundation
Start date
Mar 15th 2020
End date
Aug 14th 2024
Status
Done
Total cost
965750 HRK

DNA double-strand break (DSB) is a lethal lesion if left unrepaired, whereas its imprecise repair yields mutations and genomic rearrangements, which in humans may cause cancer and premature ageing. DSB repair is an evolutionary conserved process and hence is studied using model organisms, such as Escherichia coli. In E. coli, a process named homologous recombination (HR), wherein an intact homologous sequence serves as a template, repairs a DSB. HR is effected by a 3’-ovehang, which is produced by degrading its complementary 5’-ending strand in a process called DSB resection. Resection in E. coli is catalyzed by a RecBCD helicase/nuclease, which unwinds DNA and degrades both the unwound strands. Upon its interaction with Chi sequence of the processed DNA, RecBCD ceases degradation of the 3’ strand and starts loading RecA recombinase onto it. This project deals with some yet uncharacterized aspects of DSB repair in E. coli, using genetic, molecular biology and bioinformatics methods. We plan to determine production and the role of SSB, an essential protein, in DSB repair, specifically in illegitimate recombination. In addition, we will continue our studies of the role of exonucleases in E. coli DSB repair, as well as their phylogenetic relations and distribution in bacteria. Moreover, we plan to explore whether DSB processing in E. coli is achieved by a single or multiple rounds of helicase loading onto DNA ends, and additionally, what is the role of RecA protein in RecBCD interaction with Chi sequence. The project envisages a fundamental research that due to conserved mechanisms of DSB repair may have a medical relevance in a sense of deepening our insight into origins of cancer and the means to treat it. Another medical aspect of the project stems from better characterization of bacterial defense mechanisms involved in bacterial interaction with their human host, having repercussion on their pathogenicity and resistance to antibiotics.

This site uses cookies.. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used. For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.